Tag: AbbVie

AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It originated in 2013 as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. The “new” Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer.

First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids

AbbVie, in cooperation with Neurocrine Biosciences, Inc., announced that the FDA approved ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), with a treatment durati...

AbbVie Announces 26 Nonprofits Selected for the COVID-19 Community Resilience Fund

AbbVie announced donations to 26 nonprofit organizations totaling $5 million to support immediate COVID-19 relief efforts. Through support from the newly created AbbVie COVID-19 Community Resilience F...

AbbVie has completed its acquisition of Allergan for $63 billion

AbbVie, a research-based global biopharmaceutical company, announced that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities requ...

11th FDA Approval for IMBRUVICA Since its First Approval in 2013

abbvie
AbbVie, a research-based global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA® (ibrutinib) in combination with rituximab for the t...

AbbVie Gives up Patent Rights to Kaletra (Aluvia) amid Coronavirus Tests

abbvie
With international scrutiny focusing on a narrowing set of drugs currently in tests to treat the symptoms of the novel coronavirus, drugmakers are already facing shortages that could threaten global s...

AbbVie and Allergan Sign Agreement with FTC Staff on Pending Transaction

AbbVie, a research-based global biopharmaceutical company, and Allergan plc, a leading global pharmaceutical company, announced that they have entered into a consent decree agreement with staff of the...

EC Has Approved VENCLYXTO® (venetoclax) in Combination with Obinutuzumab

AbbVie, a research-based global biopharmaceutical company, announced that the European Commission (EC) has approved VENCLYXTO® (venetoclax) in combination with obinutuzumab for the treatment of adult ...

RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthr...

abbvie
AbbVie, a research-based global biopharmaceutical company, announced positive top-line results from the Phase 3 SELECT-PsA 1 clinical trial. In this study, both doses of RINVOQTM (upadacitinib; 15 ...

Biopharma Companies Unveiled its “multi-pronged” Response Coronavirus

As the novel coronavirus spreads around China and beyond, biopharma companies are responding with new R&D programs, donations and measures to protect employees. So far, the virus has infected more...

Nestlé is Purchasing Allergan Pancreatic Replacement Enzymes

Nestlé announced that it has entered into an asset purchase agreement with Allergan to acquire the gastrointestinal medication Zenpep. This move aims to expand the company's medical nutrition business...

AbbVie and Allergan Receive Conditional Approval from the European Commission

The European Commission approved AbbVie's merger with Allergan on the condition the companies sell off Allergan's late-stage IL-23 inhibitor brazikumab. That stipulation is far from a deal-breaker; Al...

Russian Ministry of Health Approved Upadacitinib

abbvie
The global research biopharmaceutical company AbbVie announces that the Ministry of Health of the Russian Federation has approved the RANVEC drug (upadacitinib) for oral administration once a day at a...

AbbVie and Scripps Research Announce Collaboration to Develop New Therapies

AbbVie and Scripps Research announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology and fibrosis. "Based on o...

AbbVie Announced Collaboration with Scripps Research to Develop New Therapies

AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration to develop new t...

Mission Therapeutics and AbbVie to Collaborate in AD and PD Study

alzheimer's disease
Mission Therapeutics, a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), and AbbVie, a global, research-driven biopharmaceutical company, annou...

AbbVie, NorthWest EHealth Partnered to Explore Associations Between Autoimmune Conditions

abbvie
AbbVie, a research-based global biopharmaceutical company, together with NorthWest EHealth, announces their partnership to explore the underlying associations between autoimmune conditions. The col...